


PreCision Dermatology Email Formats
Pharmaceutical Manufacturing • Cumberland, Rhode Island, United States • 11-20 Employees
PreCision Dermatology Email Formats
PreCision Dermatology uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
Key Contact at PreCision Dermatology
Rick Weisberg
President
Company overview
| Headquarters | Cumberland, Rhode Island, United States |
| Phone number | +16468959540 |
| Websites | |
| NAICS | 3254 |
| SIC | 801 |
| Founded | 2010 |
| Employees | 11-20 |
| Socials |
About PreCision Dermatology
Valeant Pharmaceuticals Completes Acquisition Of PreCision Dermatology PR Newswire -8 July 2014 - Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed the previously announced acquisition of PreCision Dermatology, Inc. PreCision develops and markets high quality dermatology products with leading products such as Locoid, Hylatopic, and Clindagel. About Valeant Pharmaceuticals International, Inc. Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
PreCision Dermatology has 8 employees across 3 departments.
Departments
Number of employees
Funding Data
PreCision Dermatology has never raised funding before.
Frequently asked questions
4.8
40,000 users



